WO2020257800A1 - System and method for improving fidelity in images - Google Patents
System and method for improving fidelity in images Download PDFInfo
- Publication number
- WO2020257800A1 WO2020257800A1 PCT/US2020/039017 US2020039017W WO2020257800A1 WO 2020257800 A1 WO2020257800 A1 WO 2020257800A1 US 2020039017 W US2020039017 W US 2020039017W WO 2020257800 A1 WO2020257800 A1 WO 2020257800A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- images
- region
- interest
- image
- pixels
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 57
- 238000002603 single-photon emission computed tomography Methods 0.000 claims description 20
- 210000000746 body region Anatomy 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 3
- 238000002604 ultrasonography Methods 0.000 claims description 3
- 230000000873 masking effect Effects 0.000 description 35
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 230000003902 lesion Effects 0.000 description 9
- 210000001165 lymph node Anatomy 0.000 description 8
- 238000011271 lymphoscintigraphy Methods 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 238000009206 nuclear medicine Methods 0.000 description 4
- PDWUPXJEEYOOTR-UHFFFAOYSA-N 2-[(3-iodophenyl)methyl]guanidine Chemical compound NC(=N)NCC1=CC=CC(I)=C1 PDWUPXJEEYOOTR-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000849 parathyroid Effects 0.000 description 2
- 210000005005 sentinel lymph node Anatomy 0.000 description 2
- 206010061728 Bone lesion Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000037194 Fever of Unknown Origin Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
- 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
- 206010052399 Neuroendocrine tumour Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
- 206010033964 Parathyroid tumour benign Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000007469 bone scintigraphy Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000002247 constant time method Methods 0.000 description 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 208000015799 differentiated thyroid carcinoma Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 208000016065 neuroendocrine neoplasm Diseases 0.000 description 1
- 201000011519 neuroendocrine tumor Diseases 0.000 description 1
- 208000010655 oral cavity squamous cell carcinoma Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000007312 paraganglioma Diseases 0.000 description 1
- 201000003686 parathyroid adenoma Diseases 0.000 description 1
- 208000014643 parathyroid gland adenoma Diseases 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Classifications
-
- G06T5/94—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/0035—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/0037—Performing a preliminary scan, e.g. a prescan for identifying a region of interest
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0073—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by tomography, i.e. reconstruction of 3D images from 2D projections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computerised tomographs
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/46—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with special arrangements for interfacing with the operator or the patient
- A61B6/461—Displaying means of special interest
- A61B6/466—Displaying means of special interest adapted to display 3D data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/486—Diagnostic techniques involving generating temporal series of image data
- A61B6/487—Diagnostic techniques involving generating temporal series of image data involving fluoroscopy
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10072—Tomographic images
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10116—X-ray image
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10132—Ultrasound image
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/20—Special algorithmic details
- G06T2207/20092—Interactive image processing based on input by user
- G06T2207/20104—Interactive definition of region of interest [ROI]
Definitions
- Lymphoscintigraphy of the head and neck with SPECT/CT is one example of a nuclear medicine exam that can pose some challenges for interpreting physicians.
- a hot injection site and associated“star artifact” can cause the look up table (LUT) to be scaled in such a way that lower activity lesions are not visible, because of the extremely high counts emitted from the injection site.
- Some anatomical features for example the sentential lymph node (SLN), usually contains less activity and emits lower counts, leading to them becoming“hidden” by the very bright injection site.
- SSN sentential lymph node
- a method of improving fidelity in an image comprises obtaining a plurality of images comprising a plurality of pixels, identifying a region of interest comprising a subset of the plurality of pixels in at least one of the images, modifying the at least one of images by reducing an intensity value of the subset of pixels in the region of interest, and normalizing the at least one image, thereby improving the fidelity of at least one feature in the plurality of images.
- the images are medical images selected from the group consisting of SPECT/CT images, PET/CT images, CT images, X-rays, and Ultrasound. In one embodiment, the images are selected from the group consisting of backscatter X-ray images, analog photographs, and digital photographs.
- the method further comprises the step of assembling the normalized images into a three-dimensional representation of an imaged region of a subject. In one embodiment, the method further comprises the steps of identifying a single-plane region of interest in at least a subset of the plurality of images, and constructing a three-dimensional region of interest from the single-plane regions of interest.
- the images are medical images comprising multiple perspective views of a body region of a subject taken from different angles.
- the method further comprises identifying a centroid of the region of interest, and reducing an intensity value of the subset of pixels in the region of interest in a gradient extending outward from the centroid.
- the region of interest is identified by a standard shape selected from the group consisting of an ellipse, and ellipsoid, a rectangle, a square, and a circle.
- the region of interest is identified by drawing a border around the region of interest.
- a system for improving fidelity in an image comprises a non-transitory computer-readable medium with instructions stored thereon, that when executed by a processor perform steps comprising obtaining a plurality of images comprising a plurality of pixels, prompting a user to select a region of interest comprising a subset of the plurality of pixels in at least one of the plurality of images, modifying the at least one image by reducing an intensity value of the subset of pixels in the region of interest, normalizing the plurality of images, thereby improving the fidelity of at least one feature in the plurality of images, and displaying the normalized images.
- the steps further comprising suggesting a region of interest for the user to select based on the intensity values of the pixels in the at least one image.
- the images are medical images comprising multiple perspective views of a body region of a subject taken from different angles.
- the steps further comprise constructing a three-dimensional representation of the body region of the subject from the multiple perspective views.
- the images are medical images and are components of a three-dimensional representation of a subject, and the region of interest can be defined in three dimensions.
- the system further comprises a user interface for displaying the normalized images, the user interface further comprising a lookup table display indicating the colors corresponding to the intensity values.
- the user interface further comprises a second original view of the plurality of images.
- the user interface further comprises a tool for selecting the region of interest by defining a standard shape selected from the group consisting of an ellipse, and ellipsoid, a rectangle, a square, and a circle.
- the user interface further comprises a tool for selecting the region of interest by drawing the region of interest over the plurality of images.
- Fig. l is a set of photographs of CT images with and without the disclosed masking technique applied;
- Fig. 2 is a pair of CT images including a LUT scale, with and without the disclosed masking technique applied;
- Fig. 3 is a pair of CT images with and without the disclosed masking technique applied
- Fig. 4 is a set of two dimensional images and a set of views of three dimensional representations of a subject
- Fig. 5 is a method of the invention.
- Fig. 6 is a graph of experimental data.
- articles“a” and“an” are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article.
- “an element” means one element or more than one element.
- range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 2.7, 3, 4, 5, 5.3, 6 and any whole and partial increments therebetween.
- software executing the instructions provided herein may be stored on a non-transitory computer-readable medium, wherein the software performs some or all of the steps of the present invention when executed on a processor.
- aspects of the invention relate to algorithms executed in computer software. Though certain embodiments may be described as written in particular programming languages, or executed on particular operating systems or computing platforms, it is understood that the system and method of the present invention is not limited to any particular computing language, platform, or combination thereof.
- Software executing the algorithms described herein may be written in any programming language known in the art, compiled or interpreted, including but not limited to C, C++, C#, Objective-C, Java, JavaScript, Python, PHP, Perl, Ruby, or Visual Basic.
- elements of the present invention may be executed on any acceptable computing platform, including but not limited to a server, a cloud instance, a workstation, a thin client, a mobile device, an embedded microcontroller, a television, or any other suitable computing device known in the art.
- Parts of this invention are described as software running on a computing device. Though software described herein may be disclosed as operating on one particular computing device (e.g. a dedicated server or a workstation), it is understood in the art that software is intrinsically portable and that most software running on a dedicated server may also be run, for the purposes of the present invention, on any of a wide range of devices including desktop or mobile devices, laptops, tablets, smartphones, watches, wearable electronics or other wireless digital/cellular phones, televisions, cloud instances, embedded microcontrollers, thin client devices, or any other suitable computing device known in the art.
- a dedicated server e.g. a dedicated server or a workstation
- software is intrinsically portable and that most software running on a dedicated server may also be run, for the purposes of the present invention, on any of a wide range of devices including desktop or mobile devices, laptops, tablets, smartphones, watches, wearable electronics or other wireless digital/cellular phones, televisions, cloud instances, embedded microcontrollers, thin client devices, or any other suitable computing device known in the art
- parts of this invention are described as communicating over a variety of wireless or wired computer networks.
- the words“network”, “networked”, and“networking” are understood to encompass wired Ethernet, fiber optic connections, wireless connections including any of the various 802.11 standards, cellular WAN infrastructures such as 3 G or 4G/LTE networks, Bluetooth®, Bluetooth® Low Energy (BLE) or Zigbee® communication links, or any other method by which one electronic device is capable of communicating with another.
- elements of the networked portion of the invention may be implemented over a Virtual Private Network (VPN).
- VPN Virtual Private Network
- One aspect of the present invention relates to a 3D post-processing method that improves medical image quality for example by increasing contrast resolution, improving low count studies, reducing oversaturation of an image, and/or helping to detect small, less visible or invisible lesions.
- the term“masking” refers to reducing the intensity of one or more pixel values in a two-dimensional or three-dimensional image.
- masking may comprise the step of setting one or more pixel values to zero.
- masking may comprise the step of calculating a centroid of a feature in an image and reducing one or more pixel values by a value in a gradient extending outward from the centroid of the feature.
- Suitable imaging techniques for use with the present invention include, but are not limited to, X-ray, CT/CAT scan, MRI, Ultrasound, proton-emission tomography, backscatter X- ray, and analog or digital photography.
- the re-normalized image data permit otherwise less visible or invisible lesions to be seen quite easily, even though the underlying counts have not changed. In the example shown in Fig. 2, the counts differ by only 2 but the formerly hidden lesion becomes easily detected following application of the 3D masking technique.
- ROI are drawn manually in all 3 planes (axial, coronal, and sagittal) and the pixel data in the ROI are reduced in intensity or removed from the SPECT (single photon emission computed tomography) data.
- This causes the software to re-normalize the data so hidden lesions may become visible.
- This is not the same as drawing a region of interest over a 2 dimensional (2D) image (Fig. 4) because in that case, the data does not get renormalized.
- 2D 2 dimensional
- ROIs may either be defined as a fixed, scalable shape (for example an ellipsoid defined either by two foci or major and minor axes), a rectangle, a circle/sphere, etc.
- an ROI may be drawn manually in order to conform to an irregular shape, for example where a high count region has a shape not easily defined as a fixed shape.
- 3D digital masking can be applied to many types of nuclear medicine SPECT/CT exams.
- Clinical SPECT applications include tumor localization, parathyroid, abscess localization, liver, lymphoscintigraphy, bone, and metaiodobenzylguanidine (MIBG).
- MIBG metaiodobenzylguanidine
- tumor localization for example Melanoma, squamous cell carcinoma of oral cavity, merkel cell carcinoma, thyroid cancers, neuroendocrine tumor, pancreatic tumor, breast cancer, carcinoid tumors, parathyroid
- Image enhancement methods disclosed herein may also be used in abscess localization, for example infections, fever of unknown origin, inflammatory process, osteomyelitis; bone scintigraphy, for example fractures, infection, and cancer, skeletal disease, and bone lesions; or MIBG, for example adrenal gland scintigraphy, Pheochromcytomas, or paragangliomas.
- a 3D Masking technique includes the steps of scanning the subject and reconstructing raw projection data to create SPECT images, viewing SPECT images in 3 planes to identify one or more candidate regions for masking, and performing a 3D masking technique by using the 3D ellipsoid or freehand masking tool to segment and remove injection site or organs with very high normal uptake.
- the technique includes the step of normalizing or re-normalizing the SPECT image color map.
- the renormalization is performed by the image viewing software . Once properly normalized, the viewer may observe the re-normalized image and observe if the 3D masking technique resulted in any additional previously hidden lesions becoming visible.
- FIG. 1 a star artifact 111 in a patient caused by a hot injection site is shown in photograph 101.
- Photographs 102 and 103 have the 3D digital masking technique applied. After the removal of the star artifact by the disclosed masking technique, a hidden lesion 104 can be visualized in photograph 103.
- the look up table (LUT) 203 is shown at the right side of both images, with the top color indicating 100%.
- the top image 201 is shown with a conventional technique.
- the bottom image 202 is shown with the 3D digital masking technique.
- the counts only differ by 2 between the images with (202) and without (201) 3D digital masking, the feature of interest 205 is much more visible in image 202 than the feature of interest 204 in image 201, due to the improved fidelity offered by the 3D digital masking technique.
- feature 204 in image 201 is measured at 117 counts and is nearly invisible, while feature 205 in image 202 is measured at 119 counts and is conspicuous.
- feature 207 in image 201 is measured at 151 counts, and is nearly invisible, while feature 208 in image 202 is measured at 153 counts, but is conspicuous.
- the disclosed method does not adjust the counts of the features of interest, but rather how regions in the image having different counts are mapped to the LUT and displayed.
- the scale of the LUT 203 it is possible to adjust the scale of the LUT 203, for example to map colors to a smaller portion of the total range of values in the image.
- performing this step fails to display the proper values because the image display bins the counted regions of the image into too small a number of bins. This in turn can lead to significant artifacts, because regions having a slightly lower count will be binned in with regions of interest (for example lesions) and may be displayed in the same color.
- the disclosed method removes regions of the image having extremely high counts and normalizes the resulting image, thereby lowering the maximum count value in the image and binning the different regions of the image more appropriately.
- images 401 and 402 are two-dimensional images.
- Image 401 has a region of interest 411 drawn to cover brightest spot.
- Image 402 has no region of interest drawn.
- Image 403 shows the result of applying the 3D digital masking technique, and shows multiple right-sided lymph nodes 413.
- Image 404 shows the result of the conventional imaging method without the disclosed 3D digital masking technique, and only shows the bright injection site 414.
- a method of improving fidelity in a medical image includes the steps of obtaining a plurality of medical images comprising a plurality of pixels in step 501, identifying a region of interest comprising a subset of the plurality of pixels in at least one of the medical images in step 502, modifying the at least one of medical images by reducing an intensity value of the subset of pixels in the region of interest in step 503, and normalizing the at least one medical image in step 505, arriving at an image or a plurality of images having at least one feature with improved fidelity 506.
- SPECT/CT was performed on a Siemens’s Symbia Intevo camera.
- the software was processed on Siemen’s Syngo application.
- the settings used were as follows: SPECT/CT: 30 sec/ view; 48 views; Collimator: LEHR; Matrix: 128x128; Orbit: Non Circular; Mode: Step and shoot; 1.0 Zoom; Care Dose4D- For CT; Slice 5mm.
- ROIs were drawn manually in all 3 planes (axial, coronal, and sagittal) over the hottest site (in lymphoscintigraphy, the hottest site is typically the injection site) and the intensity data for the pixels within the ROI were removed from the image data.
- the image LUT lookup table
- scale gray or color
- lymphoscintigraphy from 09/01/2017 - 12/31/2018 were included.
- the images in which an injection site hot spot was digitally removed improved the conspicuity of nearby nodes containing lower activity. Measured counts generally stayed the same with and without masking ( ⁇ 2 cts difference) but the renormalized LUT significantly changed the visibility of small lesions after the injection site was digitally removed by using the masking technique.
- Digital masking has improved contrast resolution and sentinel lymph node detection significantly in H/N lymphoscintigraphy.
Abstract
A method of improving fidelity in an image comprises obtaining a plurality of images comprising a plurality of pixels, identifying a region of interest comprising a subset of the plurality of pixels in at least one of the images, modifying the at least one of images by reducing an intensity value of the subset of pixels in the region of interest, and normalizing the at least one image, thereby improving the fidelity of at least one feature in the plurality of images. A system for improving fidelity in an image is also described.
Description
SYSTEM AND METHOD FOR IMPROVING FIDELITY IN IMAGES
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to US Provisional Patent Application No. 62/865,125, filed on June 21, 2019, incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
[0002] Lymphoscintigraphy of the head and neck with SPECT/CT is one example of a nuclear medicine exam that can pose some challenges for interpreting physicians. A hot injection site and associated“star artifact” can cause the look up table (LUT) to be scaled in such a way that lower activity lesions are not visible, because of the extremely high counts emitted from the injection site. Some anatomical features, for example the sentential lymph node (SLN), usually contains less activity and emits lower counts, leading to them becoming“hidden” by the very bright injection site.
[0003] Thus there is a need in the art for an improved visualization method for medical images in order to compensate for bright objects in the field of view. The present invention satisfies this need.
SUMMARY OF THE INVENTION
[0004] In one aspect, a method of improving fidelity in an image comprises obtaining a plurality of images comprising a plurality of pixels, identifying a region of interest comprising a subset of the plurality of pixels in at least one of the images, modifying the at least one of images by reducing an intensity value of the subset of pixels in the region of interest, and normalizing the at least one image, thereby improving the fidelity of at least one feature in the plurality of images.
[0005] In one embodiment, the images are medical images selected from the group consisting of SPECT/CT images, PET/CT images, CT images, X-rays, and Ultrasound. In one embodiment, the images are selected from the group consisting of backscatter X-ray images, analog photographs, and digital photographs. In one embodiment, the method further comprises the step
of assembling the normalized images into a three-dimensional representation of an imaged region of a subject. In one embodiment, the method further comprises the steps of identifying a single-plane region of interest in at least a subset of the plurality of images, and constructing a three-dimensional region of interest from the single-plane regions of interest.
[0006] In one embodiment, the images are medical images comprising multiple perspective views of a body region of a subject taken from different angles. In one embodiment, the method further comprises identifying a centroid of the region of interest, and reducing an intensity value of the subset of pixels in the region of interest in a gradient extending outward from the centroid. In one embodiment, the region of interest is identified by a standard shape selected from the group consisting of an ellipse, and ellipsoid, a rectangle, a square, and a circle. In one
embodiment, the region of interest is identified by drawing a border around the region of interest.
[0007] In one aspect, a system for improving fidelity in an image comprises a non-transitory computer-readable medium with instructions stored thereon, that when executed by a processor perform steps comprising obtaining a plurality of images comprising a plurality of pixels, prompting a user to select a region of interest comprising a subset of the plurality of pixels in at least one of the plurality of images, modifying the at least one image by reducing an intensity value of the subset of pixels in the region of interest, normalizing the plurality of images, thereby improving the fidelity of at least one feature in the plurality of images, and displaying the normalized images.
[0008] In one embodiment, the steps further comprising suggesting a region of interest for the user to select based on the intensity values of the pixels in the at least one image. In one embodiment, the images are medical images comprising multiple perspective views of a body region of a subject taken from different angles. In one embodiment, the steps further comprise constructing a three-dimensional representation of the body region of the subject from the multiple perspective views. In one embodiment, the images are medical images and are components of a three-dimensional representation of a subject, and the region of interest can be defined in three dimensions.
[0009] In one embodiment, the system further comprises a user interface for displaying the normalized images, the user interface further comprising a lookup table display indicating the
colors corresponding to the intensity values. In one embodiment, the user interface further comprises a second original view of the plurality of images. In one embodiment, the user interface further comprises a tool for selecting the region of interest by defining a standard shape selected from the group consisting of an ellipse, and ellipsoid, a rectangle, a square, and a circle. In one embodiment, the user interface further comprises a tool for selecting the region of interest by drawing the region of interest over the plurality of images.
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] The foregoing purposes and features, as well as other purposes and features, will become apparent with reference to the description and accompanying figures below, which are included to provide an understanding of the invention and constitute a part of the specification, in which like numerals represent like elements, and in which:
Fig. l is a set of photographs of CT images with and without the disclosed masking technique applied;
Fig. 2 is a pair of CT images including a LUT scale, with and without the disclosed masking technique applied;
Fig. 3 is a pair of CT images with and without the disclosed masking technique applied;
Fig. 4 is a set of two dimensional images and a set of views of three dimensional representations of a subject;
Fig. 5 is a method of the invention; and
Fig. 6 is a graph of experimental data.
DETAILED DESCRIPTION
[0011] It is to be understood that the figures and descriptions of the present invention have been simplified to illustrate elements that are relevant for a clear understanding of the present invention, while eliminating, for the purpose of clarity, many other elements found in related systems and methods. Those of ordinary skill in the art may recognize that other elements and/or
steps are desirable and/or required in implementing the present invention. However, because such elements and steps are well known in the art, and because they do not facilitate a better understanding of the present invention, a discussion of such elements and steps is not provided herein. The disclosure herein is directed to all such variations and modifications to such elements and methods known to those skilled in the art.
[0012] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, exemplary methods and materials are described.
[0013] As used herein, each of the following terms has the meaning associated with it in this section.
[0014] The articles“a” and“an” are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article. By way of example,“an element” means one element or more than one element.
[0015]“About” as used herein when referring to a measurable value such as an amount, a temporal duration, and the like, is meant to encompass variations of ±20%, ±10%, ±5%, ±1%, and ±0.1% from the specified value, as such variations are appropriate.
[0016] Throughout this disclosure, various aspects of the invention can be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 2.7, 3, 4, 5, 5.3, 6 and any whole and partial increments therebetween. This applies regardless of the breadth of the range.
[0017] In some aspects of the present invention, software executing the instructions provided herein may be stored on a non-transitory computer-readable medium, wherein the software performs some or all of the steps of the present invention when executed on a processor.
[0018] Aspects of the invention relate to algorithms executed in computer software. Though certain embodiments may be described as written in particular programming languages, or executed on particular operating systems or computing platforms, it is understood that the system and method of the present invention is not limited to any particular computing language, platform, or combination thereof. Software executing the algorithms described herein may be written in any programming language known in the art, compiled or interpreted, including but not limited to C, C++, C#, Objective-C, Java, JavaScript, Python, PHP, Perl, Ruby, or Visual Basic. It is further understood that elements of the present invention may be executed on any acceptable computing platform, including but not limited to a server, a cloud instance, a workstation, a thin client, a mobile device, an embedded microcontroller, a television, or any other suitable computing device known in the art.
[0019] Parts of this invention are described as software running on a computing device. Though software described herein may be disclosed as operating on one particular computing device (e.g. a dedicated server or a workstation), it is understood in the art that software is intrinsically portable and that most software running on a dedicated server may also be run, for the purposes of the present invention, on any of a wide range of devices including desktop or mobile devices, laptops, tablets, smartphones, watches, wearable electronics or other wireless digital/cellular phones, televisions, cloud instances, embedded microcontrollers, thin client devices, or any other suitable computing device known in the art.
[0020] Similarly, parts of this invention are described as communicating over a variety of wireless or wired computer networks. For the purposes of this invention, the words“network”, “networked”, and“networking” are understood to encompass wired Ethernet, fiber optic connections, wireless connections including any of the various 802.11 standards, cellular WAN infrastructures such as 3 G or 4G/LTE networks, Bluetooth®, Bluetooth® Low Energy (BLE) or Zigbee® communication links, or any other method by which one electronic device is capable of
communicating with another. In some embodiments, elements of the networked portion of the invention may be implemented over a Virtual Private Network (VPN).
[0021] One aspect of the present invention relates to a 3D post-processing method that improves medical image quality for example by increasing contrast resolution, improving low count studies, reducing oversaturation of an image, and/or helping to detect small, less visible or invisible lesions. As used herein, the term“masking” refers to reducing the intensity of one or more pixel values in a two-dimensional or three-dimensional image. In some embodiments, masking may comprise the step of setting one or more pixel values to zero. In some
embodiments, masking may comprise the step of calculating a centroid of a feature in an image and reducing one or more pixel values by a value in a gradient extending outward from the centroid of the feature.
[0022] Although certain exemplary embodiments are presented using one particular medical imaging technique (for example, SPECT/CT images), it is understood that the disclosed systems and methods may be used with a wide variety of medical and non-medical images to enhance fidelity. Suitable imaging techniques for use with the present invention include, but are not limited to, X-ray, CT/CAT scan, MRI, Ultrasound, proton-emission tomography, backscatter X- ray, and analog or digital photography.
[0023] In one embodiment, following masking of the injection site by segmenting the injection site in 3 dimensions and zeroing the included pixel values (3 dimensional (3D) digital masking), the re-normalized image data permit otherwise less visible or invisible lesions to be seen quite easily, even though the underlying counts have not changed. In the example shown in Fig. 2, the counts differ by only 2 but the formerly hidden lesion becomes easily detected following application of the 3D masking technique.
[0024] In one embodiment, ROI are drawn manually in all 3 planes (axial, coronal, and sagittal) and the pixel data in the ROI are reduced in intensity or removed from the SPECT (single photon emission computed tomography) data. This causes the software to re-normalize the data so hidden lesions may become visible. This is not the same as drawing a region of interest over a 2 dimensional (2D) image (Fig. 4) because in that case, the data does not get renormalized. In Fig
3, the image on the left is the conventional technique used in nuclear medicine and the image on the right is the disclosed technique with 3D digital masking.
[0025] In various embodiments, ROIs may either be defined as a fixed, scalable shape (for example an ellipsoid defined either by two foci or major and minor axes), a rectangle, a circle/sphere, etc. In some embodiments, an ROI may be drawn manually in order to conform to an irregular shape, for example where a high count region has a shape not easily defined as a fixed shape.
[0026] 3D digital masking can be applied to many types of nuclear medicine SPECT/CT exams. Clinical SPECT applications include tumor localization, parathyroid, abscess localization, liver, lymphoscintigraphy, bone, and metaiodobenzylguanidine (MIBG).
[0027] Other applications include, but are not limited to, tumor localization, for example Melanoma, squamous cell carcinoma of oral cavity, merkel cell carcinoma, thyroid cancers, neuroendocrine tumor, pancreatic tumor, breast cancer, carcinoid tumors, parathyroid
hyperplasia, parathyroid adenoma, hyperparathyroidism, differentiated thyroid cancer, hepatocellular cancer, Avid tumor, and sentinel lymph node mapping. Image enhancement methods disclosed herein may also be used in abscess localization, for example infections, fever of unknown origin, inflammatory process, osteomyelitis; bone scintigraphy, for example fractures, infection, and cancer, skeletal disease, and bone lesions; or MIBG, for example adrenal gland scintigraphy, Pheochromcytomas, or paragangliomas.
[0028] In one embodiment, a 3D Masking technique includes the steps of scanning the subject and reconstructing raw projection data to create SPECT images, viewing SPECT images in 3 planes to identify one or more candidate regions for masking, and performing a 3D masking technique by using the 3D ellipsoid or freehand masking tool to segment and remove injection site or organs with very high normal uptake. After masking, in some embodiments the technique includes the step of normalizing or re-normalizing the SPECT image color map. In some embodiments, the renormalization is performed by the image viewing software . Once properly normalized, the viewer may observe the re-normalized image and observe if the 3D masking technique resulted in any additional previously hidden lesions becoming visible.
[0029] Referring now to Fig. 1, a star artifact 111 in a patient caused by a hot injection site is shown in photograph 101. Photographs 102 and 103 have the 3D digital masking technique applied. After the removal of the star artifact by the disclosed masking technique, a hidden lesion 104 can be visualized in photograph 103.
[0030] Referring now to Fig. 2, the look up table (LUT) 203 is shown at the right side of both images, with the top color indicating 100%. The top image 201 is shown with a conventional technique. The bottom image 202 is shown with the 3D digital masking technique. Although the counts only differ by 2 between the images with (202) and without (201) 3D digital masking, the feature of interest 205 is much more visible in image 202 than the feature of interest 204 in image 201, due to the improved fidelity offered by the 3D digital masking technique.
Specifically, feature 204 in image 201 is measured at 117 counts and is nearly invisible, while feature 205 in image 202 is measured at 119 counts and is conspicuous. Similarly, feature 207 in image 201 is measured at 151 counts, and is nearly invisible, while feature 208 in image 202 is measured at 153 counts, but is conspicuous. This example shows that in one embodiment, the disclosed method does not adjust the counts of the features of interest, but rather how regions in the image having different counts are mapped to the LUT and displayed.
[0031] In some interfaces, it is possible to adjust the scale of the LUT 203, for example to map colors to a smaller portion of the total range of values in the image. However, in some embodiments performing this step fails to display the proper values because the image display bins the counted regions of the image into too small a number of bins. This in turn can lead to significant artifacts, because regions having a slightly lower count will be binned in with regions of interest (for example lesions) and may be displayed in the same color. By contrast, the disclosed method removes regions of the image having extremely high counts and normalizes the resulting image, thereby lowering the maximum count value in the image and binning the different regions of the image more appropriately.
[0032] Referring now to Fig. 3, the left image 301 is shown with the conventional technique vs image 302 on the right is shown with the 3D digital masking technique. Feature 303 in image 301 is invisible, but became visible (304) when high intensity artifacts were masked and the image renormalized using the disclosed 3D digital masking technique.
[0033] Referring now to Fig. 4, images 401 and 402 are two-dimensional images. Image 401 has a region of interest 411 drawn to cover brightest spot. Image 402 has no region of interest drawn. Image 403 shows the result of applying the 3D digital masking technique, and shows multiple right-sided lymph nodes 413. Image 404 shows the result of the conventional imaging method without the disclosed 3D digital masking technique, and only shows the bright injection site 414.
[0034] With reference now to Fig. 5, a method of improving fidelity in a medical image is shown. The method includes the steps of obtaining a plurality of medical images comprising a plurality of pixels in step 501, identifying a region of interest comprising a subset of the plurality of pixels in at least one of the medical images in step 502, modifying the at least one of medical images by reducing an intensity value of the subset of pixels in the region of interest in step 503, and normalizing the at least one medical image in step 505, arriving at an image or a plurality of images having at least one feature with improved fidelity 506.
EXPERIMENTAL EXAMPLES
[0035] The invention is further described in detail by reference to the following experimental examples. These examples are provided for purposes of illustration only, and are not intended to be limiting unless otherwise specified. Thus, the invention should in no way be construed as being limited to the following examples, but rather, should be construed to encompass any and all variations which become evident as a result of the teaching provided herein.
[0036] Without further description, it is believed that one of ordinary skill in the art can, using the preceding description and the following illustrative examples, make and utilize the system and method of the present invention. The following working examples therefore, specifically point out the exemplary embodiments of the present invention, and are not to be construed as limiting in any way the remainder of the disclosure.
Materials and Methods
[0037] SPECT/CT was performed on a Siemens’s Symbia Intevo camera. The software was processed on Siemen’s Syngo application.
[0038] The settings used were as follows: SPECT/CT: 30 sec/ view; 48 views; Collimator: LEHR; Matrix: 128x128; Orbit: Non Circular; Mode: Step and shoot; 1.0 Zoom; Care Dose4D- For CT; Slice 5mm.
[0039] ROIs were drawn manually in all 3 planes (axial, coronal, and sagittal) over the hottest site (in lymphoscintigraphy, the hottest site is typically the injection site) and the intensity data for the pixels within the ROI were removed from the image data. Following this digital masking, the image LUT (lookup table) scale (gray or color) was re-normalized by the application software. Three board certified nuclear medicine physicians reviewed the pairs of SPECT/CT exams and compared them to determine if the masking operation affected their interpretation.
Results
[0040] Forty consecutive patients who underwent SPECT/CT of head and neck
lymphoscintigraphy from 09/01/2017 - 12/31/2018 were included. In all 40 patients, the images in which an injection site hot spot was digitally removed improved the conspicuity of nearby nodes containing lower activity. Measured counts generally stayed the same with and without masking (<2 cts difference) but the renormalized LUT significantly changed the visibility of small lesions after the injection site was digitally removed by using the masking technique.
Results from H/N lymphoscintigraphy with SPECT/CT experiment:
Attending physician (A)
[0041] In 10 out of the 46 patients (20%), more lymph nodes were visible in the SPECT/CT images enhanced with the disclosed masking technique compared to the original technique.
[0042] In 3 out of the 46 patients (6%), more lymph nodes were visible in the SPECT/CT images taken with the conventional method compared to images enhanced with the disclosed masking technique.
[0043] In 12 out of 46 patients (26%), the same number of lymph nodes were visible in both the masked and unmasked images..
Attending physician (B)
[0044] In 15 out of 46 patients (33%), more lymph nodes were visible in the SPECT/CT images enhanced with the disclosed masking technique compared to the original technique.
[0045] In 1 out of 46 patients (2%), more lymph nodes were visible in the SPECT/CT images taken with the conventional method compared to images enhanced with the disclosed masking technique.
[0046] In 6 out of 46 patients (13%), the same number of lymph nodes were visible in both the masked and unmasked images.
[0047] A graphical representation of the experimental results is shown in Fig. 6 Conclusion
[0048] Digital masking has improved contrast resolution and sentinel lymph node detection significantly in H/N lymphoscintigraphy.
[0049] The disclosures of each and every patent, patent application, and publication cited herein are hereby incorporated herein by reference in their entirety. While this invention has been disclosed with reference to specific embodiments, it is apparent that other embodiments and variations of this invention may be devised by others skilled in the art without departing from the true spirit and scope of the invention. The appended claims are intended to be construed to include all such embodiments and equivalent variations.
Claims
1. A method of improving fidelity in an image, comprising:
obtaining a plurality of images comprising a plurality of pixels;
identifying a region of interest comprising a subset of the plurality of pixels in at least one of the images;
modifying the at least one of images by reducing an intensity value of the subset of pixels in the region of interest; and
normalizing the at least one image, thereby improving the fidelity of at least one feature in the plurality of images.
2. The method of claim 1, wherein the images are medical images selected from the group consisting of SPECT/CT images, PET/CT images, CT images, X-rays, and Ultrasound.
3. The method of claim 1, wherein the images are selected from the group consisting of backscatter X-ray images, analog photographs, and digital photographs.
4. The method of claim 1, further comprising the step of assembling the normalized images into a three-dimensional representation of an imaged region of a subject.
5. The method of claim 4, further comprising the steps of identifying a single-plane region of interest in at least a subset of the plurality of images; and
constructing a three-dimensional region of interest from the single-plane regions of interest.
6. The method of claim 1, wherein the images are medical images comprising multiple perspective views of a body region of a subject taken from different angles.
7. The method of claim 1, further comprising identifying a centroid of the region of interest, and
reducing an intensity value of the subset of pixels in the region of interest in a gradient extending outward from the centroid.
8. The method of claim 1, wherein the region of interest is identified by a standard shape selected from the group consisting of an ellipse, and ellipsoid, a rectangle, a square, and a circle.
9. The method of claim 1, wherein the region of interest is identified by drawing a border around the region of interest.
10. A system for improving fidelity in an image, comprising a non-transitory computer- readable medium with instructions stored thereon, that when executed by a processor perform steps comprising:
obtaining a plurality of images comprising a plurality of pixels;
prompting a user to select a region of interest comprising a subset of the plurality of pixels in at least one of the plurality of images;
modifying the at least one image by reducing an intensity value of the subset of pixels in the region of interest;
normalizing the plurality of images, thereby improving the fidelity of at least one feature in the plurality of images; and
displaying the normalized images.
11. The system of claim 7, the steps further comprising suggesting a region of interest for the user to select based on the intensity values of the pixels in the at least one image.
12. The system of claim 7, wherein the images are medical images comprising multiple perspective views of a body region of a subject taken from different angles.
13. The system of claim 12, wherein the steps further comprise constructing a three- dimensional representation of the body region of the subject from the multiple perspective views.
14. The system of claim 7, wherein the images are medical images and are components of a three-dimensional representation of a subject, and the region of interest can be defined in three dimensions.
15. The system of claim 7, further comprising a user interface for displaying the normalized images, the user interface further comprising a lookup table display indicating the colors corresponding to the intensity values.
16. The system of claim 15, the user interface further comprising a second original view of the plurality of images.
17. The system of claim 15, the user interface further comprising a tool for selecting the region of interest by defining a standard shape selected from the group consisting of an ellipse, and ellipsoid, a rectangle, a square, and a circle.
18. The system of claim 15, the user interface further comprising a tool for selecting the region of interest by drawing the region of interest over the plurality of images.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962865125P | 2019-06-21 | 2019-06-21 | |
US62/865,125 | 2019-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020257800A1 true WO2020257800A1 (en) | 2020-12-24 |
Family
ID=74040684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2020/039017 WO2020257800A1 (en) | 2019-06-21 | 2020-06-22 | System and method for improving fidelity in images |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2020257800A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110091130A1 (en) * | 2008-06-09 | 2011-04-21 | Universite De Montreal | Method and module for improving image fidelity |
US20120243761A1 (en) * | 2011-03-21 | 2012-09-27 | Senzig Robert F | System and method for estimating vascular flow using ct imaging |
US20160005154A1 (en) * | 2011-09-28 | 2016-01-07 | U.S. Army Research Laboratory Attn: Rdrl-Loc-I | System and processor implemented method for improved image quality and generating an image of a target illuminated by quantum particles |
-
2020
- 2020-06-22 WO PCT/US2020/039017 patent/WO2020257800A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110091130A1 (en) * | 2008-06-09 | 2011-04-21 | Universite De Montreal | Method and module for improving image fidelity |
US20120243761A1 (en) * | 2011-03-21 | 2012-09-27 | Senzig Robert F | System and method for estimating vascular flow using ct imaging |
US20160005154A1 (en) * | 2011-09-28 | 2016-01-07 | U.S. Army Research Laboratory Attn: Rdrl-Loc-I | System and processor implemented method for improved image quality and generating an image of a target illuminated by quantum particles |
Non-Patent Citations (2)
Title |
---|
BROCK ET AL.: "Large scale GAN training for high fidelity natural image syntheis", ARXIV:1809.11096V2, 25 February 2019 (2019-02-25), XP081088369, Retrieved from the Internet <URL:https://arxiv.org/pdf/1809.11096.pdf> [retrieved on 20200813] * |
SMELYANSKIY ET AL.: "Mapping High-Fidelity Volume Rendering for Medical Imaging to CPU, GPU and Many-Core Architectures", IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS, vol. 15, no. 6, November 2009 (2009-11-01), XP011278792, Retrieved from the Internet <URL:https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.460.3466&rep=rep1&type=pdf> [retrieved on 20200813], DOI: 10.1109/TVCG.2009.164 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11935654B2 (en) | Systems and methods for image processing | |
US10417767B2 (en) | Systems and methods for image segmentation | |
WO2020220208A1 (en) | Systems and methods for object positioning and image-guided surgery | |
US20130190602A1 (en) | 2d3d registration for mr-x ray fusion utilizing one acquisition of mr data | |
US20170032527A1 (en) | Method and system for head digitization and co-registration of medical imaging data | |
JP2016526962A5 (en) | ||
JP2020500085A (en) | Image acquisition system and method | |
US9361726B2 (en) | Medical image diagnostic apparatus, medical image processing apparatus, and methods therefor | |
CN107895390B (en) | Data processing system and method for electronic computer tomography image | |
KR20130018168A (en) | Method and device for visualizing the registration quality of medical image data sets | |
CN107220646B (en) | Medical image character recognition enhancing method for removing background interference | |
CN104240271A (en) | Image processing apparatus and method | |
US10433796B2 (en) | Selecting transfer functions for displaying medical images | |
TWI494086B (en) | Data processing device for medical treatment and radiation tomography device having the same | |
US11200727B2 (en) | Method and system for fusing image data | |
CN111243082A (en) | Method, system, device and storage medium for obtaining digital image reconstruction image | |
EP3170145B1 (en) | Imaging data statistical testing including a stereotactical normalization with a personalized template image | |
US9014448B2 (en) | Associating acquired images with objects | |
JP6526428B2 (en) | Medical image processing apparatus, medical image processing method and medical image diagnostic apparatus | |
JP6060173B2 (en) | Image processing device | |
US9514548B2 (en) | Method and system for presenting and using four dimensional data from a medical imaging system | |
US20160307358A1 (en) | Medical image processing device, medical image processing method and computer readable medium | |
WO2020257800A1 (en) | System and method for improving fidelity in images | |
US9349177B2 (en) | Extracting bullous emphysema and diffuse emphysema in E.G. CT volume images of the lungs | |
EP3423968B1 (en) | Medical image navigation system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20826584 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20826584 Country of ref document: EP Kind code of ref document: A1 |